Mutual Fund Calculator
SIP
Lumpsum
Total Invested
₹ 3,00,000
Total Interest
₹ 60,053
Total Invested
₹ 3,00,000
Estimated Returns
₹ 60,053
Total Amount after 5 years
₹ 3,60,053
Motilal Oswal Large and Midcap Fund Direct - Growth: Mutual Fund Overview
Motilal Oswal Large and Midcap Fund Direct - Growth is an Large & MidCap mutual fund with over 6.4 years of performance history. The scheme manages an AUM of ₹15017.3 Cr and has a NAV of ₹34.2079. It is rated '4' stars by analysts. Investors can begin a SIP with as little as ₹500.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 15.41%.
Motilal Oswal Large and Midcap Fund Direct-Growth
Equity
Large & MidCap
Principal at very high risk
1 Year Return13.63%
Fund Details
Know This Fund
As on 22 Aug 2026Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Latest News
Paradip port to get ₹2,008 crore boost to accelerate cargo handling
Sarbananda Sonowal inaugurated seven projects worth Rs 427.8 crore at Paradip Port, including dredging for 18.5-metre draft capability. The port signed concession agreements for three mechanisation projects worth Rs 1,580.36 crore, targeting 100% ber...
22 Aug 2026
Accel, others offload nearly 5% stake in Amagi Media Labs for Rs 587 crore
Accel, Trudy Holdings, and AVP I Fund collectively sold a 4.85% stake in Amagi Media Labs, totaling 1,04,88,021 shares for Rs 587.33 crore at Rs 560 per share via NSE block deals. Major buyers included SBI MF, Tata MF, ICICI Prudential MF, and HDFC S...
22 Aug 2026
Cabinet Secretary urges colleges to initiate programmes for advanced economy
The Cabinet Secretariat has asked ministries to create youth-focused university programmes to help India achieve advanced-economy status. Plans include process reforms, ITI upskilling, domestic digital platforms, workforce mapping, greater sports par...
22 Aug 2026
Symbiotec Pharmalab secures Rs 526 crore from anchors before Rs 1,757-cr IPO
Symbiotec Pharmalab, a Madhya Pradesh-based CDMO, raised Rs 526.2 crore from anchor investors ahead of its Rs 1,757-crore IPO, opening August 24-27 at a price band of Rs 938-988 per share. The IPO includes a Rs 150-crore fresh issue and a Rs 1,607-cr...
22 Aug 2026
Prop traders dominate derivatives gains while retail traders keep losing
Proprietary trading desks in India’s equity derivatives market earned gross profits of ₹45,955 crore in FY25 and ₹44,483 crore in FY26, largely driven by options and algorithmic trading. In contrast, individual investors lost ₹1.12 trillion and ₹91,6...
22 Aug 2026
Take Your Next Step
Talk to our investment advisor for stock recommendations
Get expert assistance for portfolio management
